PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

New report shows rare disease more common than previously thought

Of all children with epilepsy which starts in the first 3 years of age, one in four are found to have a genetic syndromeMutations in the CDKL5 gene found to be one o...
Continue Reading →
News

Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone

Three successful regulatory inspections completed in two weeks Craigavon, U.K., 25 Sep 2019 Almac Pharma Services, part of the global contract pharmaceutical ...
Continue Reading →
News

CPhI Pharmaceutical Machinery Report: ‘critical time to invest in machinery with changing drugs pipeline’

Report predicts tomorrow’s biggest industry winners will need to invest now ahead of the curve 26th September, 2019, Amsterdam: Ahead of P-MEC 2019,...
Continue Reading →
News

Huge boom in Korean Pharma reported at CPhI KoreaEvent sees new Memorandum of Understanding signed by PROLMED and KPTA.Amsterdam

The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic...
Continue Reading →
News

EASD: Lilly, BI’s Jardiance tops GLP-1s at cutting heart failure hospitalization in real-world study

BARCELONA—The GLP-1 and SGLT2 diabetes drug classes have been dueling for years now, with drugmakers gunning to produce data that give their drugs an edge. The ...
Continue Reading →
News

Roche to close Irish site by next year, plans 132 layoffs: report

After successfully selling three small molecule manufacturing plants around the world, Roche was unable to find a buyer for a site in Clarecastle, Ireland. Now,...
Continue Reading →
News

Speciality Data Aggregation: Preparing for a Successful Launch

The last decade has seen an explosion in the volume of patient-level data available to companies marketing specialty therapies. Drug manufacturers and industry busin...
Continue Reading →
News

FDA knocks Lupin plant with warning letter after drugmaker failed to remedy operational woes

Months after the FDA demanded Lupin act on failures at its Mandideep, India finished dose plant, the Indian drugmaker was waiting for the other shoe to fall. It fell...
Continue Reading →
News

Price rollbacks, Medicare negotiations, fines and more: Pharma’s likely to hate House pricing plan

House Democrats raised eyebrows last week when a draft of their drug pricing plan leaked. Now that the industry has had more than a week to pore over, second-guess a...
Continue Reading →
News

A new market reference added to Safe’n’Sound®, our passive safety device platform

A new market reference added to Safe’n’Sound®, our passive safety device platform Safe’n’Sound® is on the market in Europe with a newly registered injectable med...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026